Why can't we make an effective vaccine against Helicobacter pylori?

Expert Review of Vaccines

Volumn 12, Issue 4, 2013, Pages 433-441

  Sutton, Philip ^a,b   Chionh, Yok Teng ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

antibodies; Helicobacter pylori; problems; protective immunity; review; vaccine

Indexed keywords

HELICOBACTER PYLORI VACCINE; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; BACTERIAL COLONIZATION; CANCER GROWTH; CELL MOTILITY; DRUG FORMULATION; DRUG INDUSTRY; DRUG SAFETY; FUNDING; HELICOBACTER PYLORI; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATENT; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH17 CELL; VACCINATION; VACCINE PRODUCTION;

BACTERIAL VACCINES; DRUG DISCOVERY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84875936237     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.13.20     Document Type: Review

References (61)

1. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345(11), 784-789 (2001).
2. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann. Surg. 241(1), 27-39 (2005). (Pubitemid 40044837)
3. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342(8871), 575-577 (1993). (Pubitemid 23259233)
4. Marshall BJ, McGechie DB, Rogers PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med. J. Aust. 142(8), 439-444 (1985). (Pubitemid 15233565)
5. Stasi R, Sarpatwari A, Segal JB et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 113(6), 1231-1240 (2009).
6. Marshall BJ, Warren Jr. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390), 1311-1315 (1984).
7. Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 99(5), 1315-1323 (1990). (Pubitemid 20381865)
8. Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model. Lancet 339(8801), 1120-1121 (1992).
9. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11(6), 637-642 (1993). (Pubitemid 23142620)
10. Doidge C, Crust I, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunisation against Helicobacter infection. Lancet 343(8902), 914-915 (1994). (Pubitemid 24113641)
11. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112(4), 1386-1397 (1997). (Pubitemid 27157555)
12. Sutton P, Danon SJ, Walker M et al. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 49(4), 467-473 (2001). (Pubitemid 32896974)
13. Sutton P, Doidge C. Helicobacter pylori vaccines spiral into the new millennium. Dig. Liver Dis. 35(10), 675-687 (2003). (Pubitemid 41115415)
14. Müller A, Solnick JV. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 16(Suppl. 1), 26-32 (2011).
15. Blanchard TG, Nedrud JG. Helicobacter pylori vaccines. In: Helicobacter pylori in the 21st Century. Sutton P, Mitchell HM (Eds). CABI, Wallingford, UK, 167-189 (2010).
16. Every AL, Stent A, Moloney MB et al. Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. Vaccine 29(7), 1514-1518 (2011).
17. Bamford KB, Fan X, Crowe SE et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114(3), 482-492 (1998). (Pubitemid 28141193)
18. Shiomi S, Toriie A, Imamura S et al. IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter 13(6), 518-524 (2008).
19. Wyatt JI, Rathbone BJ, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J. Clin. Pathol. 39(8), 863-870 (1986). (Pubitemid 16045351)
20. Kimang'a A, Revathi G, Kariuki S et al. IL-17A and IL-17F gene expression is strongly induced in the mucosa of H. pylori-infected subjects from Kenya and Germany. Scand. J. Immunol. 72(6), 522-528 (2010).
21. Ermak TH, Giannasca PJ, Nichols R et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188(12), 2277-2288 (1998). (Pubitemid 29028500)
22. Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol. Cell Biol. 78(1), 28-30 (2000). (Pubitemid 30090986)
23. Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67(1), 337-341 (1999). (Pubitemid 29021667)
24. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136(1), 247-256 (2009).
25. Velin D, Favre L, Bernasconi E et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136(7), 2237-2246.e1 (2009).
26. DeLyria ES, Nedrud JG, Ernst PB et al. Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter 16(3), 169-178 (2011).
27. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129(1), 142-155 (2005). (Pubitemid 41002051)
28. Velin D, Narayan S, Bernasconi E et al. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice. Gastroenterology 141(4), 1273-82, 1282.e1 (2011).
29. Sutton P. Vaccinating against Helicobacter pylori: dissecting the mechanism. Gastroenterology 141(4), 1149-1151 (2011).
30. Nagai S, Mimuro H, Yamada T et al. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc. Natl Acad. Sci. USA 104(21), 8971-8976 (2007). (Pubitemid 47175421)
31. Tegtmeyer N, Wessler S, Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278(8), 1190-1202 (2011).
32. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300(5624), 1430-1434 (2003). (Pubitemid 36638162)
33. Radin JN, González-Rivera C, Ivie SE, McClain MS, Cover TL. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect. Immun. 79(7), 2535-2543 (2011).
34. Hoy B, Löwer M, Weydig C et al. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 11(10), 798-804 (2010).
35. Niess JH, Brand S, Gu X et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307(5707), 254-258 (2005). (Pubitemid 40116240)
36. Kao JY, Zhang M, Miller MJ et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138(3), 1046-1054 (2010).
37. Schmees C, Prinz C, Treptau T et al. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 132(5), 1820-1833 (2007). (Pubitemid 46677933)
38. Yoshida M, Claypool SM, Wagner JS et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20(6), 769-783 (2004). (Pubitemid 38757446)
39. Stent A, Every AL, Sutton P. Helicobacter pylori defense against oxidative attack. Am. J. Physiol. Gastrointest. Liver Physiol. 302(6), G579-G587 (2012).
40. Phadnis SH, Parlow MH, Levy M et al. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect. Immun. 64(3), 905-912 (1996). (Pubitemid 26065566)
41. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell. Immunol. 191(1), 74-80 (1999). (Pubitemid 29054969)
42. Michetti P, Kreiss C, Kotloff KL et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116(4), 804-812 (1999). (Pubitemid 29153528)
43. Malfertheiner P, Schultze V, Rosenkranz B et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a Phase I study. Gastroenterology 135(3), 787-795 (2008).
44. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 167(8), 821-827 (2007). (Pubitemid 46658341)
45. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J. Infect. Dis. 198(4), 553-560 (2008).
46. Amberbir A, Medhin G, Erku W et al. Effects of Helicobacter pylori, geohelminth infection and selected commensal bacteria on the risk of allergic disease and sensitization in 3-year-old Ethiopian children. Clin. Exp. Allergy 41(10), 1422-1430 (2011).
47. Arnold IC, Dehzad N, Reuter S et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J. Clin. Invest. 121(8), 3088-3093 (2011).
48. Raj SM, Choo KE, Noorizan AM, Lee YY, Graham DY. Evidence against Helicobacter pylori being related to childhood asthma. J. Infect. Dis. 199(6), 914-915; author reply
49. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 139(6), 1894-1901.e2; quiz e12 (2010).
50. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 7(12), 887-894 (2009).
51. den Hoed CM, Vila AJ, Holster IL et al. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter 16(5), 405-409 (2011).
52. Malfertheiner P, Fry LC, Mönkemüller K. Can gastric cancer be prevented by Helicobacter pylori eradication? Best Pract. Res. Clin. Gastroenterol. 20(4), 709-719 (2006). (Pubitemid 44391333)
53. Garhart CA, Redline RW, Nedrud JG, Czinn SJ. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect. Immun. 70(7), 3529-3538 (2002). (Pubitemid 34665989)
54. Tindberg Y, Blennow M, Granström M. Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection. Acta Paediatr. 88(6), 631-635 (1999). (Pubitemid 29302651)
55. Aebischer T, Bumann D, Epple HJ et al. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 57(8), 1065-1072 (2008).
56. Gerhard M. Pro: Can we make an effective vaccine against H. pylori? Presented at: 10th International Workshop on Pathogenesis and Host Response in Helicobacter Infections. Helsingør, Denmark, 4-7 July 2012. sterilizing protection against H. pylori challenge.
57. Kaparakis M, Turnbull L, Carneiro L et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell. Microbiol. 12(3), 372-385 (2010).
58. Parker H, Keenan JI. Composition and function of Helicobacter pylori outer membrane vesicles. Microbes Infect. 14(1), 9-16 (2012).
59. Doidge CV, Lee A: WO1995003824 (1993).
60. Smith D, Alm RA, Doig PC, Kabok Z, Castriotta L: WO1998/024475 (1998).
61. International Agency for Research on Cancer. GLOBOCON 2008 Cancer Fact Sheet. www-dep.iarc.fr